Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Mar 26, 2019 10:13am
89 Views
Post# 29536126

RE:RE:RE:RE:RE:RE:RE:News is out---

RE:RE:RE:RE:RE:RE:RE:News is out---
skier59 wrote: 2 things Johnny BJ. Firstly we have now established that the treatment is 100% safe and effective.
This alone makes it all the more easy to move on to point number 2. Who the hell would not want to jump in and get treated ASAP after seeing the results of Phase1b...!!!!!!!!!!

I think we will see the enrolling process move alot faster than the Phase1b.

bionicjoe wrote: Commencing in Q2 does not necessarily mean treating patients in Q2. They would likely consider enrolling patients as the official start of the trial. Has everyone already forgotten the slow progress of the phase 1b trial after they announced its start? You're also forgetting 1 key ingredient and that's FDA involvement. Without it I can't see how you can attract the attention you will need if you expect the sp some posters are quoting.




I was telling this board 2 years ago that the treatment was safe. That became obvious right from the beginning but that's not why investors are here with their wallets. You should take the company's guidance to heart. They didn't state a 2 year timeframe to complete the phase 2 trial for no reason. Some new posters are under the mistaken impression that they can make a quick buck on fast trial results. They'll soon learn.

Bullboard Posts